Marijuana for Post Traumatic Stress Disorder Study

May 18, 2011

MAPS is cur­rently seek­ing reg­u­la­tory approval to con­duct a study of smoked and/or vapor­ized mar­i­juana for symp­toms of PTSD in vet­er­ans of war.

MAPS is cur­rently the only orga­ni­za­tion work­ing to demon­strate the safety and effi­cacy of botan­i­cal mar­i­juana as a pre­scrip­tion med­i­cine for spe­cific med­ical uses to the sat­is­fac­tion of the U.S. Food and Drug Administration.

MAPS’ efforts to ini­ti­ate med­ical mar­i­juana research have been hin­dered by the National Insti­tute on Drug Abuse (NIDA) and the Drug Enforce­ment Admin­is­tra­tion (DEA) since its incep­tion in 1986. NIDA’s monop­oly on the sup­ply of mar­i­juana for research and the DEA’s refusal to allow researchers to grow their own has effec­tively par­a­lyzed med­ical mar­i­juana research, and for over ten years MAPS has been involved in legal strug­gles against the DEA to end this situation.

See below for fre­quently updated infor­ma­tion about com­pleted, ongo­ing, or planned MAPS stud­ies, as well as details of our ongo­ing DEA lawsuit.

Related Posts


Share This

Leave a Comment